C2C12-IR IGF1R knockout C2C12 cells expressing human IR-A( 41 ) (C2C12-IR) were cultured in high-glucose DMEM supplemented with 10% (v/v) FBS, 2 mM L-glutamine, and 1% penicillin/streptomycin and maintained in monolayer culture at 37 C and 5% CO2 incubator
There is no completed human efficacy trial, which is why all dosing here is research-use-only
The retired Detective/Sergeant now volunteers with the American Red Cross, carrying forward the same commitment to helping others that defined his professional career
The pivotal RECONNECT Phase 3 trials, two identically designed randomized, double-blind, placebo-controlled studies involving 1,267 women, established the peptide's therapeutic benefit
The primary endpoint was A1c change
You get a lot done, but its a grind. Despite an unusual lack of major announcements, energy is high